Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
4.310
+0.040 (0.94%)
At close: Sep 12, 2025, 4:00 PM EDT
4.290
-0.020 (-0.46%)
After-hours: Sep 12, 2025, 7:25 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $6.83 million as of September 12, 2025. Its market cap has decreased by -80.26% in one year.
Market Cap
6.83M
Enterprise Value
766.25K
1-Year Change
-80.26%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $6.83M, a decrease of -88.07%. That is a compound annual growth rate of -39.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 6.83M | -50.33% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |